Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FS6DH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,176
Award facts
- Contract value 100% obligated
- $30,175.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $30,175.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Dupixent (dupilumab) 300 mg/2 mL pens. This is a non-set-aside, competitively awarded contract with performance to be completed by August 14, 2025, and execution to occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic immunosuppressant medication used to treat moderate-to-severe eczema, asthma, and other atopic conditions, making it part of the Defense Health Agency's pharmaceutical procurement needs for military personnel and beneficiaries.
This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The SPE2DX contract functions as a comprehensive pharmaceutical supply vehicle enabling AmerisourceBergen to deliver brand-name and generic medications, biologics, vaccines, and specialized medical supplies globally to support military healthcare programs. As a major pharmaceutical distributor and prime contractor to the Defense Logistics Agency, AmerisourceBergen maintains a significant portfolio of federal medical supply contracts, positioning it as a critical vendor for military and veteran healthcare systems across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FS6DH?
SPE2DB25FS6DH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 13, 2025.
How much is contract SPE2DB25FS6DH worth?
The government has obligated $30,176 on SPE2DB25FS6DH.
Is contract SPE2DB25FS6DH an order under another contract?
Yes. SPE2DB25FS6DH is a delivery order under SPE2DB22D2214, an indefinite delivery contract.
Was contract SPE2DB25FS6DH competed?
The extent of competition for SPE2DB25FS6DH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award